dc.contributor.author | Fitton, Catherine | |
dc.contributor.author | Fleming, Michael | |
dc.contributor.author | Steiner, Markus F C | |
dc.contributor.author | Aucott, Lorna | |
dc.contributor.author | Pell, Jill P. | |
dc.contributor.author | Mackay, Daniel F | |
dc.contributor.author | McLay, James | |
dc.date.accessioned | 2020-04-15T14:30:00Z | |
dc.date.available | 2020-04-15T14:30:00Z | |
dc.date.issued | 2020-03-01 | |
dc.identifier | 153509571 | |
dc.identifier | 9df2dd4a-5412-4c33-88f4-d5e82adbdb20 | |
dc.identifier | 31884860 | |
dc.identifier | 000528832000009 | |
dc.identifier | 85081142342 | |
dc.identifier.citation | Fitton , C , Fleming , M , Steiner , M F C , Aucott , L , Pell , J P , Mackay , D F & McLay , J 2020 , ' In utero antihypertensive medication exposure and neonatal outcomes : A data linkage cohort study ' , Hypertension , vol. 75 , no. 3 , pp. 628–633 . https://doi.org/10.1161/HYPERTENSIONAHA.119.13802 | en |
dc.identifier.issn | 0194-911X | |
dc.identifier.other | ORCID: /0000-0001-6277-7972/work/84132150 | |
dc.identifier.other | unpaywall: 10.1161/hypertensionaha.119.13802 | |
dc.identifier.uri | https://hdl.handle.net/2164/14082 | |
dc.description | We acknowledge the support from the Farr Institute @ Scotland. The Farr Institute @ Scotland is supported by a 10-funder consortium: Arthritis Research UK, the British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, the Medical Research Council, the National Institute of Health Research, the National Institute for Social Care and Health Research (Welsh Assembly Government), the Chief Scientist Office (Scottish Government Health Directorates), the Wellcome Trust, (MRC grant number MR/K007017/1). | en |
dc.format.extent | 5 | |
dc.format.extent | 204548 | |
dc.language.iso | eng | |
dc.relation.ispartof | Hypertension | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | antihypertensive agents | en |
dc.subject | child | en |
dc.subject | gestational age | en |
dc.subject | hypertension | en |
dc.subject | pregnancy | en |
dc.subject | DEFECTS | en |
dc.subject | RISK | en |
dc.subject | PREGNANCY | en |
dc.subject | DELIVERY | en |
dc.subject | LABETALOL | en |
dc.subject | MAJOR CONGENITAL-MALFORMATIONS | en |
dc.subject | HYPERTENSION | en |
dc.subject | AGE | en |
dc.subject | R Medicine | en |
dc.subject | Internal Medicine | en |
dc.subject | Economic and Social Research Council (ESRC) | en |
dc.subject | Engineering and Physical Sciences Research Council (EPSRC) | en |
dc.subject | Medical Research Council (MRC) | en |
dc.subject | MR/K007017/1 | en |
dc.subject | Cancer Research UK | en |
dc.subject | Chief Scientist Office (CSO) | en |
dc.subject | MR/K007017/1 | en |
dc.subject | National Institute for Health Research (NIHR) | en |
dc.subject | British Heart Foundation | en |
dc.subject | Arthritis Research UK (ARUK) | en |
dc.subject | Wellcome Trust | en |
dc.subject | MRC Grant No: MR/K007017/1 | en |
dc.subject.lcc | R | en |
dc.title | In utero antihypertensive medication exposure and neonatal outcomes : A data linkage cohort study | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Centre for Health Data Science | en |
dc.contributor.institution | University of Aberdeen.Health Services Research Unit | en |
dc.contributor.institution | University of Aberdeen.Farr Aberdeen | en |
dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.1161/HYPERTENSIONAHA.119.13802 | |
dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85081142342&partnerID=8YFLogxK | en |
dc.identifier.vol | 75 | en |
dc.identifier.iss | 3 | en |